IRCT2016052318210N7.
Study name | Treatment of burn scars using ablative CO2 fractional laser and topical rapamycin (sirolimus) |
Methods | Randomised open‐label controlled trial |
Participants | Patients with burn hypertrophic scar who will come to RasoulAkram hospital, excluding: pregnancy or breastfeeding women, and psychological disorders that could not understand or fill consent inform. |
Interventions | Intervention 1: CO2 fractional laser: device will set with skin types of participants, anatomic place and scars colour and depth. Laser will be applied in 3 sections monthly. Intervention 2: Rapamycin cream: participants will be treated with Rapamycin 1% cream for 12 weeks. Intervention 3: combination therapy of CO2 fractional laser (on burn scars that will be applied in 3 sections monthly) added with Rapamayci 1% Cream. |
Outcomes | Primary outcome: contracture and texture. Secondary outcomes: satisfaction, skin colour, atrophy. |
Starting date | Not reported |
Contact information | Elham Behrangi: Hazrat‐e Rasool General Hospital Niyayesh St. Satarkhan St. Tehran Iran Tel:+98 (21) 66517341‐9: Elham.Behrangi@gmail.com |
Notes |